Learning phobia has long been a key obstacle in the field of higher education, hindering students’ successful development. This study proposes an innovative educational ecosystem that combines intelligent technology with olanzapine treatment, aiming to significantly reduce students’ learning anxiety and create conditions for better academic achievement.

The study recruited students from several universities who had been diagnosed with learning phobia. To assess their symptoms and performance, several standardized tools were used, including the Stanford Acute Stress Response Questionnaire (SASRQ) and the 3-Minute Disorder Assessment Scale (3D-CAM). In order to process and analyze the collected data, SPSS23.0 software was used. The software can help researchers organize, calculate, and analyze data in order to come up with relevant results about learning phobia. Through these assessment tools and statistical analysis, researchers can better understand the characteristics and influencing factors of learning phobia and provide a basis for further research and treatment.

Students who used olanzapine tablets in combination with an intelligent depression prevention system showed significant improvement in self rated learning anxiety (SASRQ) and clinical observation measurement (3D-CAM) scores, which was significantly reduced compared to students who only received traditional teaching methods.

Integrating olanzapine treatment into the comprehensive education reform of the intelligent depression prevention system provides promising potential for positively influencing students’ learning phobia. This method marks a crucial step towards advancing educational strategies and promoting good mental health among students.